Tag: preclinical imaging market drivers

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Value Outlook For The Preclinical Imaging Market Through 2030?

The preclinical imaging market has shown significant expansion in recent years. It is projected to increase from $3.69 billion in 2025 to $3.93 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. Historically, this market’s growth was primarily fueled by the increasing utilization of animal models in biomedical research, the broadening scope of oncology and neurology research, a rising adoption of non-invasive imaging techniques, an uptick in preclinical drug testing activities, and the availability of advanced imaging reagents.

The preclinical imaging market is projected to experience substantial expansion over the upcoming years, anticipated to reach a valuation of $5.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period stems from various factors such as the escalating need for real-time disease visualization, increased financial commitments to translational research, the broadening scope of precision medicine studies, the expanding application of AI-assisted image analysis, and the heightened utilization of sophisticated contrast agents. Key trends expected throughout this period include the greater uptake of multi-modal imaging platforms, an increase in the deployment of high-resolution imaging systems, the deepening integration of imaging with data analytics, the enlargement of longitudinal disease monitoring investigations, and a sharpened emphasis on the precision of translational imaging.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

What Primary Factors Are Fueling The Expansion Of The Preclinical Imaging Market?

The anticipated rise in chronic diseases is projected to fuel the expansion of the preclinical imaging market in the future. These are defined as prolonged health conditions that endure for an extended duration, generally exceeding three months. Such conditions frequently necessitate continuous medical care and can considerably affect an individual’s quality of life. Preclinical imaging tools are utilized to identify chronic diseases by visualizing aspects like bone structure and lung function. Additionally, these tools aid in studying chronic diseases to observe their progression and enhance comprehension of the conditions. As an illustration, the World Health Organization (WHO), a Switzerland-based international public health agency, reported in February 2024 that non-communicable diseases (NCDs) account for 75% (three-quarters) of all global deaths. Consequently, the growing prevalence of chronic diseases is boosting the preclinical imaging market’s expansion.

How Does Segment Analysis Break Down The Preclinical Imaging Market Structure?

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

What Trends Are Affecting The Growth Of The Preclinical Imaging Market?

Leading companies in the preclinical CRO market are integrating innovative technologies to sustain their competitive edge, such as employing a disease biology knowledge graph to refine target identification and drug discovery within pharmaceutical research. This knowledge graph offers a structured, extensive depiction of the connections among genes, proteins, pathways, and disease phenotypes, designed to consolidate diverse biological information. It empowers researchers to systematically investigate disease mechanisms, pinpoint potential therapeutic targets, and expedite drug discovery by furnishing a comprehensive overview of disease biology. For example, in February 2023, BenchSci, an AI solutions firm from Canada specializing in preclinical R&D, introduced ASCEND, a comprehensive SaaS platform dedicated to preclinical drug discovery. This platform aims to accelerate preclinical phase drug development pipelines by providing biological insights into the foundational elements of disease. ASCEND utilizes BenchSci’s machine-learning technology to extract experimental data from secure internal and public external sources. The platform then contrasts experimental outcomes against carefully assembled ontology datasets, thereby enabling the software to generate an evidence-based map of the biological processes underpinning various diseases.

Who Are The Leading Firms Participating In The Preclinical Imaging Market?

Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

Access The Complete Preclinical Imaging Market Report:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Which Region Accounts For The Highest Share Of The Preclinical Imaging Market?

North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Preclinical Imaging Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

Healthcare Cro Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

Crm Bpo Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/crm-bpo-global-market-report

Veterinary Cro And Cdmo Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Preclinical Imaging Market Expected To Change From 2026 To 2030?

The preclinical imaging market size has witnessed strong expansion over recent years. It is anticipated to increase from $3.69 billion in 2025 to $3.93 billion in 2026, at a compound annual growth rate (CAGR) of 6.7%. The surge during the historical period can be ascribed to a greater reliance on animal models in biomedical research, an amplification of oncology and neurology studies, the rising acceptance of non-invasive imaging techniques, an increase in preclinical drug testing endeavors, and the availability of advanced imaging components.

The preclinical imaging market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $5.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is primarily driven by factors such as a heightened demand for real-time disease visualization, increasing financial commitments to translational research, the broadening scope of precision medicine studies, the expanding application of AI-assisted image analysis, and the greater deployment of sophisticated contrast agents. Key trends anticipated over this period encompass a wider uptake of multi-modal imaging platforms, an increased utilization of high-resolution imaging systems, deeper integration of imaging technologies with data analytics, an expansion of longitudinal studies for disease monitoring, and a sharpened emphasis on the accuracy of translational imaging.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

Which Drivers Are Supporting The Preclinical Imaging Market Growth?

The increasing prevalence of chronic diseases is projected to drive the expansion of the preclinical imaging market moving forward. Chronic diseases are defined as long-term health conditions that persist for an extended duration, typically three months or longer. These ailments frequently demand continuous medical management and can significantly impact an individual’s quality of life. For the identification of chronic diseases, preclinical imaging tools are utilized to visualize elements such as bone structure and lung function. They are also instrumental in studying chronic diseases to observe their progression and deepen understanding. For instance, in February 2024, the World Health Organization (WHO), a Switzerland-based agency overseeing international public health, stated that NCDs are responsible for 75% (three-quarters) of all global deaths. Therefore, the rise in chronic diseases is acting as a significant catalyst for the growth of the preclinical imaging market.

How Are Segments Identified Within The Preclinical Imaging Market Segment Framework?

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

Which Trends Are Expected To Impact The Preclinical Imaging Market?

Leading companies active in the preclinical imaging market are heightening their emphasis on releasing next-generation imaging systems to secure a competitive advantage. Next-generation imaging systems are defined as sophisticated and groundbreaking technologies that exceed current capacities by integrating cutting-edge features. For example, in September 2023, Revvity Inc., a US-based biotechnology company, introduced next-generation imaging systems crafted to propel innovation across various preclinical research applications. The recently unveiled products encompass the next-generation IVIS Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that effortlessly combines 2D optical and full 3D imaging. These imaging systems offer enhanced image-based functionalities and are engineered to optimize the imaging workflow.

Who Are The Companies Competing Within The Preclinical Imaging Market?

Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

Get The Full Preclinical Imaging Market Report:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Which Region Has The Greatest Market Share In The Preclinical Imaging Market?

North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Preclinical Imaging Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

Healthcare Cro Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

Crm Bpo Market Report

https://www.thebusinessresearchcompany.com/report/crm-bpo-global-market-report

Veterinary Cro And Cdmo Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Preclinical Imaging Market At The End Of The 2026–2030 Forecast Period?

The preclinical imaging market size has experienced robust expansion over recent years. This market is projected to expand from $3.69 billion in 2025 to $3.93 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. Historically, this expansion has been driven by factors such as the greater utilization of animal models in biomedical research, the enlargement of oncology and neurology research, the increasing acceptance of non-invasive imaging methods, a rise in preclinical drug testing efforts, and the accessibility of sophisticated imaging reagents.

The preclinical imaging market is anticipated to experience substantial expansion in the coming years, projected to reach $5.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This projected growth is driven by several factors, including heightened demand for real-time disease visualization, increased investments in translational research, the broadening of precision medicine studies, the expanding application of AI-assisted image analysis, and the greater implementation of advanced contrast agents. Concurrently, major trends expected during this period involve the growing embrace of multi-modal imaging platforms, the increased utilization of high-resolution imaging systems, the deeper integration of imaging with data analytics, the enlargement of longitudinal disease monitoring studies, and a sharpened emphasis on translational imaging accuracy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

Which Market Drivers Are Supporting The Expansion Of The Preclinical Imaging Market?

The rising incidence of chronic diseases is projected to drive the growth of the preclinical imaging market in the future. Chronic diseases are long-term health conditions that persist for an extended duration, usually three months or longer. These conditions often require continuous medical management and can significantly impact a person’s quality of life. Preclinical imaging tools are employed to identify chronic diseases through the visualization of bone structure and lung function. They are also used to investigate chronic diseases, allowing researchers to visualize disease progression and enhance understanding. For example, in February 2024, according to the World Health Organization (WHO), a Switzerland-based agency focused on international public health, non-communicable diseases (NCDs) are responsible for 75% (three-quarters) of all deaths worldwide. Consequently, the increasing prevalence of chronic diseases is propelling the expansion of the preclinical imaging market.

What Segment Types Make Up The Preclinical Imaging Market?

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

What Trends Are Affecting The Expansion Of The Preclinical Imaging Market?

Leading companies within the preclinical imaging market are increasingly focusing on introducing advanced imaging systems to gain a competitive advantage. Next-generation imaging systems denote sophisticated and innovative technologies that extend beyond current capabilities, incorporating cutting-edge features. For example, in September 2023, Revvity Inc., a US-based biotechnology company, released next-generation imaging systems developed to foster innovation across various applications in preclinical research. The new products include the next-generation IVIS Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that smoothly combines 2D optical and full 3D imaging. These imaging systems offer improved image-based functionalities and are engineered to optimize the imaging workflow.

Who Are The Key Players Driving Competition In The Preclinical Imaging Market?

Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

Read the full preclinical imaging market report here:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

How Is The Preclinical Imaging Market Distributed Across Key Geographic Regions?

North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Preclinical Imaging Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

Healthcare Cro Services Global Market Report

https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

Crm Bpo Global Market Report

https://www.thebusinessresearchcompany.com/report/crm-bpo-global-market-report

Veterinary Cro And Cdmo Global Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model